I can't get no satisfaction - Still no neuroprotection for Parkinson disease

被引：5

作者：

Ahlskog, J. Eric ^{[1
]}

机构：

[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA

来源：

NEUROLOGY | 2007年 / 69卷 / 15期

关键词：

D O I：

10.1212/01.wnl.0000277645.60799.0e

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1476 / 1477

页数：2

共 16 条

[1] Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].

Banati, RB ;

Daniel, SE ;

Blunt, SB .

MOVEMENT DISORDERS, 1998, 13 (02) :221-227

[2] CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ-induced cortical neuron apoptosis [J].

Bozyczko-Coyne, D ;

O'Kane, TM ;

Wu, ZL ;

Dobrzanski, P ;

Murthy, S ;

Vaught, JL ;

Scott, RW .

JOURNAL OF NEUROCHEMISTRY, 2001, 77 (03) :849-863

[3] Cell death in the nervous system [J].

Bredesen, Dale E. ;

Rao, Rammohan V. ;

Mehlen, Patrick .

NATURE, 2006, 443 (7113) :796-802

[4]

Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO

[5]

2-F

[6] Cell death mechanisms in Parkinson's disease [J].

Jellinger, KA .

JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (01) :1-29

[7] Targeting the JNK Signaling Pathway for Stroke and Parkinson's Diseases Therapy [J].

Kuan, Chia-Yi ;

Burke, Robert E. .

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (01) :63-67

[8] The role of c-jun N-terminal kinase (JNK) in Parkinson's disease [J].

Peng, J ;

Andersen, JK .

IUBMB LIFE, 2003, 55 (4-5) :267-271

[9] Neuroprotective agents for clinical trials in Parkinson's disease - A systematic assessment [J].

Ravina, BM ;

Fagan, SC ;

Hart, RG ;

Hovinga, CA ;

Murphy, DD ;

Dawson, TM ;

Marler, JR .

NEUROLOGY, 2003, 60 (08) :1234-1240

[10] MPTP activates c-Jun NH2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo [J].

Saporito, MS ;

Thomas, BA ;

Scott, RW .

JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :1200-1208

← 1 2 →